Skip to main content
Professional Technical IVT

experimental autoimmune encephalomyelitis

Also written as: EAE — experimental autoimmune encephalomyelitis

An animal model of multiple sclerosis induced by immunization with CNS antigens.

Full Definition

Experimental autoimmune encephalomyelitis (EAE) is the most widely used animal model for studying multiple sclerosis and testing potential therapies. The condition is induced in laboratory animals by immunizing them with myelin proteins or peptides, leading to T-cell mediated inflammation and demyelination in the central nervous system. EAE closely mimics many pathological features of human MS, including inflammatory infiltrates, demyelination, and clinical symptoms such as paralysis. Different EAE protocols can model various aspects of MS, from acute monophasic disease to chronic progressive forms.

Usage

Usage note: Commonly abbreviated as EAE; spell out on first use in clinical documents.

In Context

  • "The experimental autoimmune encephalomyelitis model showed significant improvement with treatment." — Preclinical study
  • "EAE induction was performed using MOG peptide in complete Freund's adjuvant." — Methods section

Also known as

EAE

Don't confuse with

autoimmune encephalitis acute disseminated encephalomyelitis

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON